| 000 | 01405 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513121850.0 | ||
| 264 | 0 | _c19970904 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a0361-9230 | ||
| 024 | 7 |
_a10.1016/s0361-9230(96)00346-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDomino, E F | |
| 245 | 0 | 0 |
_aSelective full dopamine D1-like (SKF-82958) and D2-like (N-0923) agonist combination in the MPTP monkey model of hemiparkinsonism. _h[electronic resource] |
| 260 |
_bBrain research bulletin _c1997 |
||
| 300 |
_a93-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzazepines _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aMacaca nemestrina |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 |
_aReceptors, Dopamine D1 _xagonists |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xagonists |
| 650 | 0 | 4 |
_aTetrahydronaphthalenes _xpharmacology |
| 650 | 0 | 4 |
_aThiophenes _xpharmacology |
| 773 | 0 |
_tBrain research bulletin _gvol. 43 _gno. 1 _gp. 93-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0361-9230(96)00346-2 _zAvailable from publisher's website |
| 999 |
_c9186281 _d9186281 |
||